Coronary Restenosis
📧 Sign up to get email alerts when something new happens for Coronary Restenosis.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2009-02-06Clinical Trial Update: Serp-1 for the Treatment of Acute Coronary Syndrome [Phase 2]
A Phase 2 trial of Serp-1 for acute coronary syndrome has been terminated; the study enrolled patients with unstable angina, coronary artery…
-
CLINICAL_TRIALS trial_result · 2008-12-15Clinical Trial Update: SPIRIT III Clinical Trial of the XIENCE V® Everolimus Eluting Coronary Stent System (EECSS) [Phase 3]
SPIRIT III was a Phase 3 study evaluating the XIENCE V everolimus-eluting coronary stent system; the trial completed and results were posted…
-
CLINICAL_TRIALS trial_result · 2008-08-01Clinical Trial Update: PIoglitazone for PrEvention of Restenosis in Diabetic Patients [Phase 3]
A Phase 3 clinical trial investigating pioglitazone for preventing restenosis in patients with diabetes; current status is unknown.
-
CLINICAL_TRIALS trial_result · 2007-02-08Clinical Trial Update: Safety and Efficacy of RESTEN-MP When Used in Conjunction With a Bare Metal Stent in Coronary Arteries [Phase 2]
Phase 2 trial assessing the safety and efficacy of RESTEN-MP when used with a bare metal coronary stent in patients with coronary artery dis…
-
CLINICAL_TRIALS trial_result · 2007-01-24Clinical Trial Update: Systemic Treatment With Everolimus for the Prevention of MACE After Bare Metal Stent Implantation [Phase 3]
Phase 3 trial evaluating systemic everolimus to prevent major adverse cardiac events after bare metal stent implantation.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2006-12-15Clinical Trial Update: Clinical and Angiographic Outcomes With Hyperglycemic Control Post PCI [NA]
A completed clinical trial update assessing whether tight glycemic control after percutaneous coronary intervention improves clinical and an…
-
CLINICAL_TRIALS trial_result · 2006-12-12Clinical Trial Update: Treatment of in-Stent Restenosis by Paclitaxel Coated PTCA Balloons (PACCOCATH - ISR II) [Phase 1, Phase 2]
Completed Phase 1/2 study evaluating paclitaxel-coated PTCA balloons (PACCOCATH ISR II) for treatment of in-stent restenosis.